title: Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed after 17 years of propylthiouracil therapy.
authors.affiliation: Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, 783-8505, Japan, ttagu27k@axel.ocn.ne.jp.
authors.forename: Takafumi
authors.initials: T
authors.lastname: Taguchi
authors.forename: Shuichi
authors.initials: S
authors.lastname: Nakayama
authors.forename: Simpei
authors.initials: S
authors.lastname: Fujimoto
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Terada
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D013956:Antithyroid Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006111:Graves Disease / Q000188:drug therapy; D006801:Humans; D008181:Lupus Nephritis / Q000139:chemically induced / Q000175:diagnosis* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009195:Peroxidase / Q000276:immunology*; D011441:Propylthiouracil / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D013956:Antithyroid Agents; D011441:Propylthiouracil; D009195:Peroxidase